Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 COVID-19 1

Interventions

Standard of Care 8 Hydroxychloroquine 4 BNT162 Vaccine 4 Practice Guidelines as Topic 3 Blood Specimen Collection 3 2019-nCoV Vaccine mRNA-1273 3 tocilizumab 2 sotrovimab 2 cilgavimab and tixagevimab drug combination 2 Specimen Handling 2 Sodium Chloride 2 CVnCoV COVID-19 vaccine 2 COVID-19 Vaccines 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 sinovac COVID-19 vaccine 1 selinexor 1 remdesivir 1 proxalutamide 1 palbociclib 1 ogalvibart 1 monalizumab 1 lenzilumab 1 crexavibart 1 ciclesonide 1 bemcentinib 1 avdoralimab 1 acalabrutinib 1 XAV-19 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × COVID-19 × lenzilumab × Clear all

NCT04534725 2023-08-24

C-SMART

Peter MacCallum Cancer Centre, Australia

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡